サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1493221

オルソバイオロジクス市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年

Orthobiologics Market Size, Share & Trends Analysis Report By Product (DBM, Allograft, BMP, Viscosupplementation), By Application (Spinal Fusion, Trauma Repair), By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
オルソバイオロジクス市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年
出版日: 2024年05月10日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

オルソバイオロジクス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のオルソバイオロジクス市場規模は、2024年から2030年にかけてCAGR 5.5％を記録し、2030年には93億米ドルに達すると予測されています。

世界中で整形外科手術の症例が増加していることが、オルソバイオロジクスの需要を促進しています。米国整形外科学会（AAOS）の2023年年次総会で発表された研究では、整形外科医が人工関節全置換術（TJA）の需要増に対応するという課題に直面することが明らかになった。この調査によると、需要に対応するためには、外科医はTJAの症例数を2倍にするか、5年ごとに外科医の数を10％増やす必要があるといいます。

ヘルスケアの進歩と患者の転帰への注目が高まる中、世界各国の政府は、オルソバイオロジクスの成長を促進するための政策やイニシアチブを実施しています。例えば、米国整形外科学会（AAOS）は、透明で科学的な方法で筋骨格系ケアの改善に取り組んでいます。2020年10月、AAOSはウェブサイトに生物製剤ダッシュボードを開設し、整形外科医が生物学的製剤を用いた治療法の承認状況を把握できるようにしました。このイニシアチブはAAOS Biologics Initiativeの一部であり、筋骨格系の健康コミュニティにエビデンスに基づいたガイダンスを提供するものです。この取り組みの一環として、AAOS理事会は生物製剤に関連する2つのポジションステートメントも改訂しました。

世界中で老年人口が増加していることも、整形外科手術の需要を押し上げると予想されています。India Ageing Report 2023によると、インドの高齢者人口は急速なペースで増加しており、10年ごとの増加率は41％です。2050年までに、インドの人口の20％以上が高齢者になると予想されています。高齢になると、骨粗しょう症、変形性関節症、骨折など、筋肉や骨に問題が生じる可能性が高くなります。その結果、オルソバイオロジクスに対するニーズが高まる。

さらに、交通事故の増加も市場の成長を補うと予想されています。米国道路交通安全局の報告によると、2023年上半期の自動車事故による死亡者数は推定19,515人でした。これは、死亡者数が20,190人であった前年同期と比べて約3.3％減少したことになります。また、2023年第1四半期、第2四半期ともに死亡者数は減少しています。このように、負傷者数の増加は、オルソバイオロジクスの需要を増加させると予想されます。

同市場で事業を展開する主要企業は、製品形成とリーチを強化することに主眼を置いて、提携、供給契約、パートナーシップなどの戦略を採用しています。例えば、2023年9月、HippoFi Inc.はZimmer Biomet Holdings Inc.と提携し、骨成長のための合成バイオマテリアルを発表しました。このバイオマテリアルは、2024年にHippoFiの生物製剤子会社PUR Biologicsの下で発売される予定です。

生物製剤市場のハイライト

  • 製品別では、関節内補充療法分野が2023年に市場で最大の売上高シェアを占めたが、これは生活習慣病の有病率の増加とヒアルロン酸療法開発の進歩によるものです。
  • 用途別では、変性椎間板疾患の罹患率の上昇により、脊椎固定術分野が2023年の市場で最大の収益シェアを占めました。
  • 最終用途別では、外科手術を受ける患者の増加により、病院セグメントが最大の収益シェアを占めました。
  • 北米は、複数の市場プレーヤーが存在し、規制の枠組みが確立されているため、市場を独占しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 世界のオルソバイオロジクス市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
  • オルソバイオロジクス：市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTLE分析
  • 規制の枠組み

第4章 世界のオルソバイオロジクス市場セグメント分析、製品別、2018年-2030年

  • 定義と範囲
  • 製品タイプ市場シェア分析、2023年および2030年
  • セグメントダッシュボード
  • 世界のオルソバイオロジクス市場、製品タイプ別、2018～2030年
  • 脱灰骨基質（DBM）
  • 同種移植
  • 骨形成タンパク質（BMP）
  • 関節内補充療法
  • 合成骨代替物
  • 幹細胞療法

第5章 世界のオルソバイオロジクス市場セグメント分析、用途別、2018年-2030年

  • 定義と範囲
  • 用途市場シェア分析、2023年および2030年
  • セグメントダッシュボード
  • 世界のオルソバイオロジクス市場、用途別、2018～2030年
  • 脊椎固定術
  • 外傷修復
  • 再建手術

第6章 世界のオルソバイオロジクス市場セグメント分析、最終用途別、2018年-2030年

  • 定義と範囲
  • 最終用途市場シェア分析、2023年および2030年
  • セグメントダッシュボード
  • 世界のオルソバイオロジクス市場、最終用途別、2018～2030年
  • 病院
  • 外来施設

第7章 世界のオルソバイオロジクス市場セグメント分析、地域別、2018年-2030年

  • 地域別市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 地域市場のスナップショット
  • 地域別オルソバイオロジクス市場シェア、2023年および2030年
  • 北米
    • 北米のオルソバイオロジクス市場、2018年-2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州のオルソバイオロジクス市場、2018年-2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 企業プロファイル
    • Medtronic Plc
    • DePuy Synthes
    • Zimmer Biomet
    • Stryker Corporation
    • Bioventus LLC
    • Seaspine Holdings Corporation
    • Orthofix, Inc.
    • Globus Medical
    • Arthrex, Inc.
    • Bone Biologics Corp.
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global orthobiologics market, by region, 2018 - 2030 (USD Billion)
  • Table 4 Global orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 5 Global orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 6 Global orthobiologics market, by end use, 2018 - 2030 (USD Billion)
  • Table 7 North America orthobiologics market, by region, 2018 - 2030 (USD Billion)
  • Table 8 North America orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 9 North America orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 10 North America orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 11 U.S. orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 12 U.S. orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 13 U.S. orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 14 Canada orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 15 Canada orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 16 Canada orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 17 Europe orthobiologics market, by region, 2018 - 2030 (USD Billion)
  • Table 18 Europe orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 19 Europe orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 20 Europe orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 21 Germany orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 22 Germany orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 23 Germany orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 24 UK orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 25 UK orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 26 UK orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 27 France orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 28 France orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 29 France orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 30 Italy orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 31 Italy orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 32 Italy orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 33 Spain orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 34 Spain orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 35 Spain orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 36 Denmark orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 37 Denmark orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 38 Denmark orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 39 Sweden orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 40 Sweden orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 41 Sweden orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 42 Norway orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 43 Norway orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 44 Norway orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 45 Asia Pacific orthobiologics market, by region, 2018 - 2030 (USD Billion)
  • Table 46 Asia Pacific Orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 47 Asia Pacific orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 48 Asia Pacific orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 49 China orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 50 China orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 51 China orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 52 Japan orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 53 Japan orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 54 Japan orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 55 India orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 56 India orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 57 India orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 58 South Korea orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 59 South Korea orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 60 South Korea orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 61 Australia orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 62 Australia orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 63 Australia orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 64 Thailand orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 65 Thailand Orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 66 Thailand Orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 67 Latin America orthobiologics market, by region, 2018 - 2030 (USD Billion)
  • Table 68 Latin America orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 69 Latin America orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 70 Latin America orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 71 Brazil orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 72 Brazil orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 73 Brazil orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 74 Mexico orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 75 Mexico orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 76 Mexico orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 77 Argentina orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 78 Argentina orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 79 Argentina orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 80 MEA orthobiologics market, by region, 2018 - 2030 (USD Billion)
  • Table 81 MEA orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 82 MEA orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 83 MEA orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 84 South Africa orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 85 South Africa orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 86 South Africa orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 87 Saudi Arabia orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 88 Saudi Arabia orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 89 Saudi Arabia orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 90 UAE orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 91 UAE orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 92 UAE orthobiologics market, by end-use, 2018 - 2030 (USD Billion)
  • Table 93 Kuwait orthobiologics market, by product, 2018 - 2030 (USD Billion)
  • Table 94 Kuwait orthobiologics market, by application, 2018 - 2030 (USD Billion)
  • Table 95 Kuwait orthobiologics market, by end-use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Orthobiologics market: outlook
  • Fig. 9 Orthobiologics competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Orthobiologics market driver impact
  • Fig. 12 Orthobiologics market restraint impact
  • Fig. 13 Porter's Analysis
  • Fig. 14 PESTLE Analysis
  • Fig. 15 Orthobiologics market: Product movement analysis
  • Fig. 16 Orthobiologics market: Product outlook and key takeaways
  • Fig. 17 Demineralized bone matrix (DBM) market estimates and forecast, 2018 - 2030
  • Fig. 18 Allograft estimates and forecast, 2018 - 2030
  • Fig. 19 Bone morphogenetic protein (BMP) estimates and forecast, 2018 - 2030
  • Fig. 20 Viscosupplementation estimates and forecast, 2018 - 2030
  • Fig. 21 Synthetic bone substitutes estimates and forecast, 2018 - 2030
  • Fig. 22 Stem cell therapy estimates and forecast, 2018 - 2030
  • Fig. 23 Orthobiologics Market: Application movement Analysis
  • Fig. 24 Orthobiologics market: Application outlook and key takeaways
  • Fig. 25 Spinal fusion market estimates and forecasts, 2018 - 2030
  • Fig. 26 Trauma repair market estimates and forecasts, 2018 - 2030
  • Fig. 27 Reconstructive surgery market estimates and forecasts, 2018 - 2030
  • Fig. 28 Orthobiologics market: End-use movement analysis
  • Fig. 29 Orthobiologics market: End-use outlook and key takeaways
  • Fig. 30 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 31 Outpatient facilities market estimates and forecasts, 2018 - 2030
  • Fig. 32 Global orthobiologics market: Regional movement analysis
  • Fig. 33 Global orthobiologics market: Regional outlook and key takeaways
  • Fig. 34 North America orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 35 Key country dynamics
  • Fig. 36 U.S. orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 37 Key country dynamics
  • Fig. 38 Canada orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 39 Europe orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 40 Key country dynamics
  • Fig. 41 UK orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 42 Key country dynamics
  • Fig. 43 Germany orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 44 Key country dynamics
  • Fig. 45 Spain orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 46 Key country dynamics
  • Fig. 47 France orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 48 Key country dynamics
  • Fig. 49 Italy orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 50 Key country dynamics
  • Fig. 51 Norway orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 52 Key country dynamics
  • Fig. 53 Denmark orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 54 Key country dynamics
  • Fig. 55 Sweden orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 56 Asia Pacific orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 57 Key country dynamics
  • Fig. 58 Japan orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 59 Key country dynamics
  • Fig. 60 China orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 61 Key country dynamics
  • Fig. 62 India orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 63 Key country dynamics
  • Fig. 64 Australia orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 65 Key country dynamics
  • Fig. 66 South Korea orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 67 Key country dynamics
  • Fig. 68 Thailand orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 69 Latin America orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 70 Key country dynamics
  • Fig. 71 Brazil orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 72 Key country dynamics
  • Fig. 73 Mexico orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 74 Key country dynamics
  • Fig. 75 Argentina orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 76 MEA orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 77 Key country dynamics
  • Fig. 78 South Africa orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 79 Key country dynamics
  • Fig. 80 Saudi Arabia orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 81 Key country dynamics
  • Fig. 82 UAE orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 83 Key country dynamics
  • Fig. 84 Kuwait orthobiologics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 85 Key company categorization
  • Fig. 86 Heat map analysis, 2022 - 2023
目次
Product Code: GVR-1-68038-360-7

Orthobiologics Market Growth & Trends:

The global orthobiologics market size is expected to reach USD 9.3 billion by 2030, registering a CAGR of 5.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing cases of orthopedic surgeries across the globe is driving the demand for orthobiologics. A study presented at the Annual Meeting of the American Academy of Orthopedic Surgeons (AAOS) 2023, revealed that orthopedic surgeons would face a challenge in meeting the increasing demand for total joint arthroplasty (TJA). The study found that to keep up with the demand, surgeons will have to either double their TJA caseload or increase the number of surgeons by 10% every five years.

With an increasing focus on healthcare advancements and patient outcomes, governments worldwide are implementing policies and initiatives to foster the growth of orthobiologics. For instance, the American Academy of Orthopedic Surgeons (AAOS) is committed to improving musculoskeletal care in a transparent and scientific way. In October 2020, the AAOS launched the Biologics Dashboard on their website, which is designed to assist orthopedic surgeons in keeping track of the approval status of biologic-based interventions. This initiative is a part of the AAOS Biologics Initiative, which offers evidence-based guidance to the musculoskeletal health community. As part of this effort, the AAOS Board of Directors also revised two position statements related to biologics.

Increasing geriatric population across the globe is also anticipated to boost the demand for orthopedic surgeries. According to the India Ageing Report 2023, country's elderly population is growing at a rapid pace, with a decadal growth rate of 41%. By 2050, over 20% of India's population will be elderly citizens.As people age, they are more likely to experience issues with their muscles and bones, such as osteoporosis, osteoarthritis, and fractures. This results in a greater need for orthobiologics solutions.

Moreover, increasing cases of road accidents is anticipated to supplement the market growth. According to the National Highway Traffic Safety Administration report, there were an estimated 19,515 deaths in motor vehicle accidents during the first half of 2023. This represents a decrease of about 3.3% compared to the same period in the previous year, which had 20,190 fatalities. The report also shows that fatalities decreased during both the first and second quarters of 2023. Thus, the increasing number of injured populations is expected to increase the demand for orthobiologics.

The major players operating in the market are adopting strategies such as collaborations, supply agreements, and partnerships with a major focus on enhancing the product formation and reach. For instance, inSeptember 2023, HippoFi Inc. partnered with Zimmer Biomet Holdings Inc. to bring forth a synthetic biomaterial for bone growth. The biomaterial will be launched under HippoFi's biologic subsidiary, PUR Biologics in 2024.

Orthobiologics Market Report Highlights:

  • Based on product, the viscosupplementation segment held the largest revenue share in the market in 2023 owing to the increasing prevalence of lifestyle-related conditions and advances in hyaluronic acid therapy development
  • Based on application, the spinal fusion segment held the largest revenue share in the market in 2023 owing to the rising incidence of degenerative disc disease
  • Based on end-use, the hospitals segment accounted for the largest revenue share due to the growing patient population undergoing surgical procedures
  • North America dominated the market due to the presence of several market players and a well-established regulatory framework

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Global Orthobiologics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Orthobiologics: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis
  • 3.4. Regulatory Framework

Chapter 4. Global Orthobiologics Market Segment Analysis, By Product, 2018 - 2030 (USD Billion)

  • 4.1. Definition and Scope
  • 4.2. Product Type Market Share Analysis, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Orthobiologics Market, by Product Type, 2018 to 2030
  • 4.5. Demineralized Bone Matrix (DBM)
    • 4.5.1. Demineralized Bone Matrix (DBM) market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.6. Allograft
    • 4.6.1. Allograft market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.7. Bone morphogenetic protein (BMP)
    • 4.7.1. Bone morphogenetic protein (BMP) market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.8. Viscosupplementation
    • 4.8.1. Viscosupplementation market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.9. Synthetic bone substitutes
    • 4.9.1. Synthetic bone substitutes market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.10. Stem cell therapy
    • 4.10.1. Stem cell therapy market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. Global Orthobiologics Market Segment Analysis, By Application, 2018 - 2030 (USD Billion)

  • 5.1. Definition and Scope
  • 5.2. Application Market Share Analysis, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global orthobiologics Market, by Application, 2018 to 2030
  • 5.5. Spinal Fusion
    • 5.5.1. Spinal fusion market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.6. Trauma repair
    • 5.6.1. Trauma repair market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.7. Reconstructive surgery
    • 5.7.1. Reconstructive surgery market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 6. Global Orthobiologics Market Segment Analysis, By End-use, 2018 - 2030 (USD Billion)

  • 6.1. Definition and Scope
  • 6.2. End-use Market Share Analysis, 2023 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Orthobiologics Market, by end-use, 2018 to 2030
  • 6.5. Hospitals
    • 6.5.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 6.6. Outpatient facilities
    • 6.6.1. Outpatient facilities market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 7. Global Orthobiologics Market Segment Analysis, By Region, 2018 - 2030 (USD Billion)

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Regional Market Snapshot
  • 7.4. Orthobiologics Market Share by Region, 2023 & 2030
  • 7.5. North America
    • 7.5.1. North America orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.5.2. U.S.
      • 7.5.2.1. U.S. orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.5.3. Canada
      • 7.5.3.1. Canada orthobiologics market, 2018 - 2030 (USD Billion)
  • 7.6. Europe
    • 7.6.1. Europe orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.6.2. UK
      • 7.6.2.1. UK orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.6.3. Germany
      • 7.6.3.1. Germany orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.6.4. France
      • 7.6.4.1. France orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.6.5. Italy
      • 7.6.5.1. Italy orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.6.6. Spain
      • 7.6.6.1. Spain orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.6.7. Norway
      • 7.6.7.1. Norway orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.6.8. Sweden
      • 7.6.8.1. Sweden orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.6.9. Denmark
      • 7.6.9.1. Denmark orthobiologics market, 2018 - 2030 (USD Billion)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Japan orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.7.2. China
      • 7.7.2.1. China orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.7.3. India
      • 7.7.3.1. India orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.7.4. Australia
      • 7.7.4.1. Australia orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.7.5. South Korea
      • 7.7.5.1. South Korea orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.7.6. Thailand
      • 7.7.6.1. Thailand orthobiologics market, 2018 - 2030 (USD Billion)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Brazil orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.8.2. Mexico
      • 7.8.2.1. Mexico orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.8.3. Argentina
      • 7.8.3.1. Argentina orthobiologics market, 2018 - 2030 (USD Billion)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. South Africa orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Saudi Arabia orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.9.3. UAE
      • 7.9.3.1. UAE orthobiologics market, 2018 - 2030 (USD Billion)
    • 7.9.4. Kuwait
      • 7.9.4.1. Kuwait orthobiologics market, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Profiles
    • 8.3.1. Medtronic Plc
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. DePuy Synthes
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Zimmer Biomet
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Stryker Corporation
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Bioventus LLC
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Seaspine Holdings Corporation
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Orthofix, Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Globus Medical
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Arthrex, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Bone Biologics Corp.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives